Axomove Raises €4M Series A for Digital Health Growth

French digital health innovator, Axomove, has successfully closed a €4 million Series A funding round. This significant capital injection is earmarked to accelerate the deployment of its digital medical device, which focuses on the prevention and rehabilitation of musculoskeletal conditions. The company's mission centers on leveraging movement to sustainably improve clinical outcomes and patient care pathways for conditions like chronic lower back pain.

The funding round was notably co-led by Bpifrance, through its Digital Prevention Fund, and GO CAPITAL. Demonstrating continued confidence in the venture, existing investor Faraday Venture Partners also participated, alongside INCO Ventures. This strategic investment underscores the growing recognition of digital therapeutics within the healthcare ecosystem.

Investors highlighted Axomove's strong foundational elements, including its status as a reimbursed solution integrated within the French healthcare system. The product has already achieved market validation, showcasing measurable clinical results. This is particularly impactful in a large, yet still largely undigitized, sector of healthcare. Axomove stands out as the sole solution in its category to receive public health funding in France for chronic lower back pain treatment, solidifying its position in the European health tech market.

The newly acquired capital will fuel Axomove's expansion across three key strategic areas. Firstly, the company plans to broaden its commercial reach by forging partnerships with insurers, corporations, and healthcare providers. Secondly, it aims to extend reimbursement coverage to address a wider spectrum of pathologies. Finally, ongoing product enhancement and user experience improvements are central to the growth strategy.

The digital health market, particularly in Europe, is experiencing robust growth, driven by an aging population, increasing prevalence of chronic diseases, and a growing demand for accessible and cost-effective healthcare solutions. The global digital health market size was valued at over USD 200 billion in 2023 and is projected to expand at a significant CAGR in the coming years. Axomove's focus on evidence-based, reimbursed digital interventions positions it well to capture a substantial share of this expanding market.

This funding round represents a pivotal moment for Axomove, enhancing its scalability and its capacity to influence health systems more broadly. The company's commitment to data-driven patient care and its successful integration into national health frameworks provide a strong blueprint for future success in the competitive digital therapeutics arena.